1. Home
  2. LIXT vs MRIN Comparison

LIXT vs MRIN Comparison

Compare LIXT & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • MRIN
  • Stock Information
  • Founded
  • LIXT 2005
  • MRIN 2006
  • Country
  • LIXT United States
  • MRIN United States
  • Employees
  • LIXT N/A
  • MRIN N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • LIXT Health Care
  • MRIN Technology
  • Exchange
  • LIXT Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • LIXT 4.1M
  • MRIN 4.6M
  • IPO Year
  • LIXT N/A
  • MRIN 2013
  • Fundamental
  • Price
  • LIXT $1.22
  • MRIN $1.34
  • Analyst Decision
  • LIXT
  • MRIN
  • Analyst Count
  • LIXT 0
  • MRIN 0
  • Target Price
  • LIXT N/A
  • MRIN N/A
  • AVG Volume (30 Days)
  • LIXT 31.7K
  • MRIN 18.4K
  • Earning Date
  • LIXT 03-24-2025
  • MRIN 05-01-2025
  • Dividend Yield
  • LIXT N/A
  • MRIN N/A
  • EPS Growth
  • LIXT N/A
  • MRIN N/A
  • EPS
  • LIXT N/A
  • MRIN N/A
  • Revenue
  • LIXT N/A
  • MRIN $16,707,999.00
  • Revenue This Year
  • LIXT N/A
  • MRIN N/A
  • Revenue Next Year
  • LIXT N/A
  • MRIN N/A
  • P/E Ratio
  • LIXT N/A
  • MRIN N/A
  • Revenue Growth
  • LIXT N/A
  • MRIN N/A
  • 52 Week Low
  • LIXT $1.02
  • MRIN $1.30
  • 52 Week High
  • LIXT $3.80
  • MRIN $5.46
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 41.29
  • MRIN 29.16
  • Support Level
  • LIXT $1.15
  • MRIN $1.30
  • Resistance Level
  • LIXT $1.31
  • MRIN $1.59
  • Average True Range (ATR)
  • LIXT 0.11
  • MRIN 0.06
  • MACD
  • LIXT 0.03
  • MRIN 0.01
  • Stochastic Oscillator
  • LIXT 43.24
  • MRIN 13.79

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: